홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Tamoxifen Citrate

HCID 2733525
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
54965-24-1
표준 SMILES
CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
InChIKey
FQZYTYWMLGAPFJ-OQKDUQJOSA-N
분자식
C32H37NO8
평균 분자량
563.6 g/mol
단동위원소 질량
563.25191714

개요

Tamoxifen Citrate can cause developmental toxicity according to state or federal government labeling requirements.

이름 및 식별자

우선 이름
Tamoxifen Citrate
IUPAC
2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid
영어명
Tamoxifen citrate
분자식
C32H37NO8
분자량
563.64

이름 및 동의어

Tamoxifen citrate54965-24-1ZitazoniumKessarZemideJenoxifenLedertamNourytamTamofeneNoxitemOncotamTamofen
이름 더 보기
NOLVADEXtamoxifeneTMXSoltaMoxNolvadex(Tamoxifen)Tamoxifen Citrate TabletsTamoxifen Z-isomer citrate(Z)-[2-[4-(1,2-diphenylbut-1-enyl)phenoxy]ethyl]dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylateTMX1TXNDC
TomaxastaZynoplexEmblonNolgenNoltamTamaxICI 46,474DTXSID8021301

데이터베이스 식별자

CAS
54965-24-1
PubChem CID
2733525
DTXSID
DTXSID8021301
ChEMBL
CHEMBL786
UNII
7FRV7310N6
EC Number
259-415-2

물성

구조 계산 물성

극성 표면적
145 Ų
수소 결합 공여자 수
4
수소 결합 수용자 수
9
회전 가능 결합 수
13
무거운 원자 수
41
형식 전하
0
복잡도
690

실험 및 물리화학적 성질

Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section197.2 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
140 · 140-144 °C
저장 조건
2 · 2-8°C
용해도
50 mg/mL, · 메탄올: 용해성50mg/mL, 투명, 무색
물리적 상태
가루
색상
흰색에서 황백색까지
생물학적 소스
rabbit
수용성
약간 용해됨
Merck
14 · 14,9048
BCS Class
1 · 1
안정성
1 · 제공된 대로 구매일로부터 1년 동안 안정적입니다. DMSO의 솔루션은 -20°에서 최대 2개월 동안 보관할 수 있습니다.
주요 응용
의약품(소분자)
InChIKey
FQZYTYWMLGAPFJ-OQKDUQJOSA-N
SMILES
C(/C1=CC=CC=C1)(\C1C=CC(OCCN(C)C)=CC=1)=C(/CC)\C1=CC=CC=C1.C(O)(C(=O)O)(CC(=O)O)CC(=O)O

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H302 (97.4%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P263, P264, P270, P273, P280, P301+P317, P318, P330, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 78 reports by companies from 14 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory Information · 2건

Hazard Traits - Developmental Toxicity

Tamoxifen citrate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1): Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (97.4%)

독성 정보

Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Tamoxifen citrate

vMost-DILI-concern

8

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

안전 데이터

wgk
3
rtecs
KH2387000
ridadr
UN 3077 9 / PGIII
독성
LD50 in mice, rats (mg/kg): 200, 600 i.p.; 62.5, 62.5 i.v.; 3000-6000, 1200-2500 orally (Furr, Jordan)

화학 및 산업

약리 정보

FDA Pharmacological Classification · 2건

TAMOXIFEN CITRATE

Selective Estrogen Receptor Modulators [MoA]; Estrogen Agonist/Antagonist [EPC]

MeSH Pharmacological Classification · 4건

Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.

Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)

A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.

응용 분야 · 3건

개요Tamoxifen is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective effects in permanent focal ischemia. Inhibits PKC. Potent agonist at GPR30 (membrane estrogen receptor). Clinically useful breast cancer agent.

용도Tamoxifen Citrate is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4.

관련 반응

2건
반응 기록 만들기
HRID 348778 반응식
HRID 348778반응물로
HRID 553327 반응식
HRID 553327반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
EPA
Tamoxifen citrate (54965-24-1)
화학적 성질 · 1건

Tamoxifen citrate is a white to off-white powder with no smell. It can dissolve in methanol, ethanol, and acetone to varying degrees and can slightly dissolve in trichloromethane, but it is almost insoluble in water. It can dissolve in glacial acetic acid. When tamoxifen citrate reaches a temperature between 142-148°C, it melts and decomposes at the same time.

HS 번호
29225090
risk_code
45-60-61-22-64-36/37/38
hazard_code
T,Xi
safety_code
53-36/37/39-45-36-26
위험 등급
IRRITANT
Hazard Classifications
Acute Tox. 4 OralAquatic Acute 1Aquatic Chronic 1Carc. 1BRepr. 1B
스토리지 클래스
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

일반 설명Tamoxifen, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine(Nolvadex), is a triphenylethylene SERM used to treatearly and advanced breast carcinoma in postmenopausalwomen. Tamoxifen is used as adjuvant treatment for breastcancer in women following mastectomy and breast irradiation.It reduces the occurrence of contralateral breast cancerin patients receiving adjuvant tamoxifen therapy. It is alsoeffective in the treatment of metastatic breast cancer in bothwomen and men. In premenopausal women with metastaticbreast cancer, tamoxifen is an alternative to oophorectomyor ovarian irradiation. Tamoxifen can be used preventativelyto reduce the incidence of breast cancer in women athigh risk. Antiestrogenic and estrogenic side effects caninclude hot flashes, nausea, vomiting, platelet reduction,and (in patients with bone metastases) hypercalcemia. Likeall triphenylethylene derivatives, it should be protectedfrom light.

상·하류 제품 정보

상류 원료

염화알루미늄4-브로모페놀에틸브로마이드페닐초산마그네슘브로모벤젠타목시펜알파-[4-[2-(디메틸아미노)에톡시]페닐]-베타-에틸-알파-페닐페네틸알코올Tamoxifen citrate